MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Companies

Companies

Displaying 1..10 of 145 - per page Next page
Order by
King's College London Business Ltd is responsible for commercialisation of technologies emanating from King's. Opportunities include: Collaborative & Contract research, Consultancy, Clinical trials. More
NRC-BRI's Health and Bioprocess Sectors promote and conduct innovative collaborations, services and technology transfers with the biotechnology and pharmaceutical industries. More
Bioneer is a CRO research based company within recombinant protein production, immuno-regulatory assays, drug characterization and formulation and diagnostic biomarkers. More
NorthShore University HealthSystem Research Institute More
The University of Edinburgh has an international reputation for world-class research in medicine and biotechnology. More
BTG is an international specialty pharmaceuticals company that is developing and commercialising products targeting critical care, cancer, neurological and other disorders. More
LeadDiscovery offers intelligence services to the drug discovery sector. Focusing on pre-clinical research and analysis for identification and development of new therapeutic entities More
SIRS-Lab produces molecular diagnostic systems to identify life-threatening infections. The main objective is early and targeted antibiotic therapy of sepsis, the leading cause of death in hospitals. More
QMUL aims to create social and economic benefits for society by developing a culture of innovation and enterprise that will facilitate the commercial exploitation of academic research and technology. More
Protheon brings a novel concept of protein folding into a user-friendly protein expression platform and endeavors to develop live influenza vaccine for prevention of seasonal and pandemic influenza. More
Displaying 1..10 of 145 - per page Next page
Order by

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
BioTrinity
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us